Supreme Court Cans Allergan’s Tribal Patent Deal

Drug Industry Daily
The Supreme Court has scotched Allergan’s attempt to hide a patent for one of its blockbuster drugs in a Native Tribe’s reservation—but the case is only different in degree from what has become common practice in the drug industry, a legal expert tells FDAnews.

To View This Article:


Subscribe To Drug Industry Daily